S

Satori Pharmaceuticals

50 employees

Satori Pharmaceuticals develops disease-modifying therapies for alzheimer's, parkinson's and other neurodegenerative disorders.

Basic info

Industry

biotechnology

Sectors

Neuroscience
Health Care
Pharmaceutical

Date founded

2005

Funding rounds raised

Total raised

$22M

from 9 investors over 9 rounds

S

Satori Pharmaceuticals raised $15M on February 23, 2012

Investors: Prospect Venture Partners, LP and InterWest Partners

S

Satori Pharmaceuticals raised $7M on January 5, 2011

Investors: InterWest Partners, PureTech Health and Prospect Venture Partners, LP

S

Satori Pharmaceuticals raised $22M on January 8, 2009

Investors: Prospect Venture Partners, LP, InterWest Partners and PureTech Health

S

Satori Pharmaceuticals raised $3M on January 1, 2005

Investors: PureTech Health

FAQ